{"meshTags":["Female","Diagnosis, Differential","Protein-Tyrosine Kinases","Middle Aged","Adolescent","World Health Organization","Antibodies, Monoclonal","Survival Rate","Lymphoma, T-Cell","Receptor Protein-Tyrosine Kinases","Humans","Adult","Lymphoma, B-Cell","Male","Antigens, CD30","Lymphoma, Large B-Cell, Diffuse"],"meshMinor":["Female","Diagnosis, Differential","Protein-Tyrosine Kinases","Middle Aged","Adolescent","World Health Organization","Antibodies, Monoclonal","Survival Rate","Lymphoma, T-Cell","Receptor Protein-Tyrosine Kinases","Humans","Adult","Lymphoma, B-Cell","Male","Antigens, CD30","Lymphoma, Large B-Cell, Diffuse"],"publicationTypes":["Journal Article","Review"],"title":"Anaplastic large cell lymphoma: redefining its morphologic spectrum and importance of recognition of the ALK-positive subset.","pubmedId":"10021895"}